MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Leary, K. A.
Right arrow Articles by Perry, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Leary, K. A.
Right arrow Articles by Perry, M. E.
Molecular and Cellular Biology, January 2004, p. 186-191, Vol. 24, No. 1
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.1.186-191.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Mdm2 Regulates p53 Independently of p19ARF in Homeostatic Tissues

Kathleen A. O'Leary, Susan M. Mendrysa,{dagger} Abram Vaccaro, and Mary Ellen Perry*

Department of Oncology, University of Wisconsin, Madison, Wisconsin 53706, Regulation of Protein Function Laboratory, Center for Cancer Research, National Cancer Institute—Frederick, Frederick, Maryland 21702

Received 17 June 2003/ Returned for modification 21 August 2003/ Accepted 8 October 2003

Tumor suppressor proteins must be exquisitely regulated since they can induce cell death while preventing cancer. For example, the p19ARF tumor suppressor (p14ARF in humans) appears to stimulate the apoptotic function of the p53 tumor suppressor to prevent lymphomagenesis and carcinogenesis induced by oncogene overexpression. Here we present a genetic approach to defining the role of p19ARF in regulating the apoptotic function of p53 in highly proliferating, homeostatic tissues. In contrast to our expectation, p19ARF did not activate the apoptotic function of p53 in lymphocytes or epithelial cells. These results demonstrate that the mechanisms that control p53 function during homeostasis differ from those that are critical for tumor suppression. Moreover, the Mdm2/p53/p19ARF pathway appears to exist only under very restricted conditions.


* Corresponding author. Mailing address: National Cancer Institute, EPN Rm. 5034, 6130 Executive Blvd., Bethesda, MD 20892-7396. Phone: (301) 451-6447. Fax: (301) 402-1037. E-mail: perryma{at}mail.nih.gov.

{dagger} Present address: Fred Hutchinson Cancer Research Center, Seattle, WA 98109.


Molecular and Cellular Biology, January 2004, p. 186-191, Vol. 24, No. 1
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.1.186-191.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.